GO:2000001 regulation of DNA damage checkpoint: Cell Cycle Arrest Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000001 (regulation of DNA damage checkpoint) is a biological process that modulates the frequency, rate or extent of a DNA damage checkpoint, which arrests the cell cycle to allow repair.
• The DNA damage checkpoint is a signal transduction cascade that senses DNA lesions and transmits arrest signals to the cell cycle machinery, primarily through ATM/ATR-CHK1/CHK2-p53 signaling.
• Dysregulation of this checkpoint is a hallmark of cancer, where loss of checkpoint control leads to genomic instability and tumor progression.
• Checkpoint recovery is an active process requiring phosphatases and chromatin modifications, such as histone H4T80 phosphorylation, to restart the cell cycle after repair.
• Beyond cancer, the DNA damage checkpoint intersects with immune responses, influencing lymphocyte development and immunotherapy outcomes.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the causal roles of checkpoint regulators in disease and therapy.
Description
The DNA damage checkpoint is a surveillance mechanism that halts cell cycle progression when DNA is damaged, allowing time for repair and preventing the propagation of mutations. The Gene Ontology term GO:2000001, regulation of DNA damage checkpoint, encompasses any process that modulates the frequency, rate or extent of this checkpoint. This regulation is critical for maintaining genomic integrity and is orchestrated by a network of sensor, transducer, and effector proteins, including ATM, ATR, CHK1, CHK2, and p53. Dysregulation of the DNA damage checkpoint is directly linked to cancer, where checkpoint inactivation permits uncontrolled proliferation despite DNA damage, and to chemoresistance, where checkpoint activation protects tumor cells from DNA-damaging agents. Recent studies have also revealed roles for checkpoint regulators in immune cell development and function, highlighting the broad physiological importance of this process. Understanding how the checkpoint is regulated at the molecular level is therefore essential for developing targeted therapies and for interpreting genome-wide screens. This article provides a research-grade overview of GO:2000001, integrating authoritative Gene Ontology annotations with verified PubMed literature. It covers the definition, core mechanisms, key genes, disease associations, and experimental models, with a focus on CRISPR-based approaches for functional validation.
regulation of DNA damage checkpoint At A Glance
| GO ID | GO:2000001 |
|---|---|
| GO term | regulation of DNA damage checkpoint |
| Ontology | biological_process |
| Synonym | regulation of DNA damage response, signal transduction resulting in cell cycle arrest |
| Major function | Modulates the frequency, rate or extent of a DNA damage checkpoint, which arrests the cell cycle to allow DNA repair |
| Key regulators | ATM, ATR, CHK1, CHK2, p53, CDC25, WEE1, and histone modifications |
| Disease relevance | Cancer, genomic instability, chemoresistance, and immune disorders |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, and flow cytometry |
What Is GO:2000001?
GO:2000001, regulation of DNA damage checkpoint, is defined as any process that modulates the frequency, rate or extent of a DNA damage checkpoint. In practice, this includes the activation, maintenance, adaptation, and recovery phases of the checkpoint signaling cascade that arrests the cell cycle in response to DNA lesions. The term is synonymous with regulation of DNA damage response, signal transduction resulting in cell cycle arrest.
Why Is regulation of DNA damage checkpoint Important in Cell Biology?
Regulation of the DNA damage checkpoint is fundamental to genome stability and cell survival. It ensures that cells with damaged DNA do not enter mitosis, preventing mutations that could lead to cancer. Moreover, checkpoint regulators are frequently mutated or dysregulated in human cancers, making them attractive targets for therapeutic intervention. Understanding the precise mechanisms of checkpoint regulation can inform the development of inhibitors (e.g., CHK1/CHK2 inhibitors) and guide combination therapies with DNA-damaging agents.
• Prevents genomic instability by arresting the cell cycle at G1/S, intra-S, and G2/M transitions in response to DNA damage.
• Coordinates DNA repair with cell cycle progression, ensuring repair completion before mitosis.
• Loss of checkpoint function leads to accumulation of mutations and is a hallmark of cancer.
• Checkpoint activation contributes to chemoresistance by allowing tumor cells to repair therapy-induced damage.
• Regulates immune cell development and responses, linking DNA damage to immunity.
• Checkpoint recovery is an active process essential for resuming proliferation after repair.
• Provides targets for cancer therapy, such as ATM, ATR, CHK1, and WEE1 inhibitors.
• Involved in aging and neurodegenerative diseases through its role in maintaining neuronal genome integrity.
• Modulated by RNA-binding proteins like SRSF2, which safeguard transcription of DNA damage and repair genes.
• Regulated by hMOB2, a component of the Hippo pathway, linking cell cycle checkpoints to organ size control.
What Happens During regulation of DNA damage checkpoint?
DNA Damage Sensing and Checkpoint Activation
In simple terms: When DNA is damaged, sensor proteins detect the damage and start a signaling chain that pauses the cell cycle.
The DNA damage checkpoint is initiated by sensor proteins such as ATM and ATR, which recognize DNA double-strand breaks and single-stranded DNA, respectively. ATM is activated by the MRN complex (MRE11-RAD50-NBS1) at double-strand breaks, while ATR is recruited by RPA-coated single-stranded DNA. These kinases phosphorylate downstream effectors, including CHK1 and CHK2, which amplify the signal and propagate it to cell cycle regulators. This activation phase is tightly regulated to ensure a rapid and robust response to genotoxic stress.
Signal Transduction to Cell Cycle Machinery
In simple terms: The damage signal is relayed to proteins that control the cell cycle, stopping progression until repair is done.
Activated CHK1 and CHK2 phosphorylate CDC25 phosphatases, leading to their inhibition or degradation. CDC25 normally activates CDK-cyclin complexes that drive cell cycle transitions; their inhibition prevents entry into mitosis. Additionally, p53 is stabilized and activated by ATM/ATR and CHK1/CHK2, leading to transcription of CDK inhibitor p21, which enforces G1/S and G2/M arrest. This signal transduction ensures that the cell cycle is halted at multiple checkpoints.
Checkpoint Maintenance and DNA Repair
In simple terms: While the cell cycle is paused, repair proteins fix the DNA damage.
During the arrest, DNA repair pathways such as homologous recombination and non-homologous end joining are activated. The checkpoint machinery also recruits repair factors to damage sites and modulates chromatin structure to facilitate repair. For example, phosphorylation of histone H4 at threonine 80 (H4T80) by CK2 promotes checkpoint recovery by recruiting repair proteins. The maintenance phase is critical for ensuring that repair is completed before the cell cycle resumes.
Checkpoint Recovery and Cell Cycle Resumption
In simple terms: Once DNA is repaired, the checkpoint is turned off and the cell cycle restarts.
Checkpoint recovery is an active process that requires inactivation of checkpoint kinases and reactivation of CDC25. Phosphatases such as WIP1 (PPM1D) dephosphorylate ATM, CHK1, and CHK2, reversing the checkpoint signal. Additionally, histone H4T80 phosphorylation triggers recovery by promoting the removal of checkpoint proteins from damage sites. This step is essential to prevent permanent arrest or cell death and to allow normal tissue homeostasis.
Regulation by RNA-Binding Proteins and Chromatin Modifiers
In simple terms: Other proteins, like RNA-binding factors and chromatin modifiers, fine-tune the checkpoint response.
Recent studies have shown that RNA-binding proteins such as SRSF2 regulate the expression of DNA damage and repair genes, thereby influencing checkpoint efficiency. SRSF2 depletion leads to reduced transcription of these genes and impaired checkpoint activation. Similarly, hMOB2, a component of the Hippo signaling pathway, regulates DNA damage responses and cell cycle progression, linking checkpoint control to tissue growth. These additional layers of regulation ensure that the checkpoint is appropriately tuned to cellular context.
Key Genes Involved in GO:2000001 regulation of DNA damage checkpoint
The following genes and proteins are central to the regulation of the DNA damage checkpoint, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | Sensor kinase that initiates checkpoint signaling at DNA double-strand breaks | Target for radiosensitization; mutated in ataxia-telangiectasia |
| ATR | Sensor kinase that responds to single-stranded DNA and replication stress | Inhibitor development for cancer therapy |
| CHEK1 (CHK1) | Effector kinase that phosphorylates CDC25 and enforces checkpoint arrest | Target for chemopotentiation; involved in replication stress response |
| CHEK2 (CHK2) | Effector kinase activated by ATM; phosphorylates p53 and CDC25 | Germline mutations linked to cancer predisposition |
| TP53 | Transcription factor that induces p21 and other genes to enforce cell cycle arrest | Most frequently mutated tumor suppressor; key for checkpoint maintenance |
| CDKN1A (p21) | CDK inhibitor that mediates p53-dependent cell cycle arrest | Biomarker of p53 activity; target for modulating chemosensitivity |
| CDC25A | Phosphatase that activates CDK2; inhibited by CHK1/CHK2 to enforce arrest | Overexpressed in cancers; target for degradation inducers |
| CDC25C | Phosphatase that activates CDK1; inhibited to prevent mitotic entry | Regulated by CHK1; involved in G2/M checkpoint |
| WEE1 | Kinase that phosphorylates CDK1 to prevent mitotic entry | Target for cancer therapy, especially in p53-deficient tumors |
| SRSF2 | RNA-binding protein that safeguards transcription of DNA damage and repair genes | Mutations in myelodysplasia; affects checkpoint gene expression |
| MOB2 | Regulator of DNA damage responses and cell cycle progression | Links Hippo pathway to checkpoint control |
| H4T80 | Histone modification that triggers checkpoint recovery | Phosphorylation by CK2; marker of recovery |
| PPM1D (WIP1) | Phosphatase that dephosphorylates ATM, CHK1, CHK2 to promote recovery | Amplified in cancers; target for inhibition |
| MDC1 | Mediator protein that amplifies ATM signaling at damage sites | Required for efficient checkpoint activation |
| RAD50 | Component of MRN complex that activates ATM | Mutations cause Nijmegen breakage syndrome-like disorders |
| NBN (NBS1) | Component of MRN complex; recruits ATM to damage sites | Mutated in Nijmegen breakage syndrome |
| RPA | Binds single-stranded DNA to recruit ATR | Essential for ATR-mediated checkpoint |
How Is regulation of DNA damage checkpoint Regulated?
The DNA damage checkpoint is regulated at multiple levels, including post-translational modifications, protein-protein interactions, and transcriptional control. Phosphorylation by ATM/ATR and CHK1/CHK2 is central, but phosphatases such as WIP1 reverse these modifications to allow recovery. Chromatin modifications, including histone H4T80 phosphorylation, also regulate checkpoint recovery. Additionally, RNA-binding proteins like SRSF2 influence the expression of checkpoint genes, adding a layer of transcriptional regulation. The Hippo pathway component hMOB2 further modulates checkpoint activity, linking it to cell growth and proliferation signals.
regulation of DNA damage checkpoint and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Li-Fraumeni syndrome, multiple cancers | Knockout or point-mutation knock-in in cancer cell lines |
| ATM | Ataxia-telangiectasia, cancer predisposition | Knockout in lymphoblastoid cells or iPSCs |
| CHEK2 | Hereditary breast and colon cancer | Knockout in HCT116 or MCF7 cells |
| SRSF2 | Myelodysplastic syndromes | Point mutation knock-in (P95H) in hematopoietic cells |
| MOB2 | Cancer and developmental disorders | Overexpression or knockout in HEK293T cells |
Cancer and Genomic Instability
Dysregulation of the DNA damage checkpoint is a hallmark of cancer. Mutations in TP53, ATM, or CHEK2 impair checkpoint function, leading to genomic instability and tumor progression. Conversely, hyperactivation of the checkpoint can confer resistance to DNA-damaging chemotherapies, as tumor cells arrest and repair damage. Targeting checkpoint kinases such as CHK1, WEE1, or ATR is a promising therapeutic strategy to force cancer cells into mitosis with unrepaired DNA, leading to mitotic catastrophe.
Immune Disorders and Lymphocyte Development
The DNA damage checkpoint is critical for immune cell development, particularly during V(D)J recombination and class switch recombination in lymphocytes. Defects in checkpoint genes can lead to immunodeficiency or autoimmunity. For example, ATM deficiency causes ataxia-telangiectasia, characterized by immunodeficiency and cancer predisposition. Understanding checkpoint regulation in immune cells may inform immunotherapy approaches.
Neurodegeneration and Aging
Neurons are post-mitotic but still require DNA repair and checkpoint-like responses to maintain genome integrity. Defects in DNA damage response proteins, including ATM and p53, are associated with neurodegenerative diseases and accelerated aging. The checkpoint kinase p53 plays a dual role, promoting repair or apoptosis depending on the extent of damage, and its dysregulation contributes to neuronal loss.
Myelodysplasia and Splicing Factor Mutations
Mutations in the splicing factor SRSF2 are common in myelodysplastic syndromes and are associated with impaired transcription of DNA damage and repair genes. This leads to defective checkpoint activation and genomic instability, contributing to disease pathogenesis. Targeting the DNA damage response in SRSF2-mutant cells may offer therapeutic opportunities.
From regulation of DNA damage checkpoint-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATM abolish the G2/M checkpoint? | ATM knockout cell line (e.g., HEK293T or HCT116) |
| Does a specific p53 mutation affect checkpoint maintenance? | TP53 point-mutation knock-in (e.g., R175H) in isogenic cell lines |
| Does SRSF2 mutation impair transcription of DNA repair genes? | SRSF2 P95H knock-in in K562 or CD34+ cells |
| Does overexpression of hMOB2 enhance checkpoint activation? | MOB2 overexpression in HEK293T cells |
| Does histone H4T80 phosphorylation regulate checkpoint recovery? | H4T80A or H4T80D knock-in in HeLa cells |
| Can CRISPR library screening identify novel checkpoint regulators? | Genome-wide CRISPR knockout library in p53-deficient cells |
How to Study the regulation of DNA damage checkpoint Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identify novel checkpoint regulators |
| Phosphoproteomics | Kinase substrate phosphorylation | Map ATM/ATR signaling networks |
| Live-cell imaging | Cell cycle progression and DNA damage foci | Monitor checkpoint activation and recovery |
| Flow cytometry | Cell cycle distribution and apoptosis | Quantify G1/S and G2/M arrest |
| RNA-seq | Transcriptional changes and splicing | Analyze p53-dependent gene expression |
| ChIP-seq | Chromatin occupancy of checkpoint proteins | Map binding of p53 or ATM at damage sites |
| Immunoblotting | Protein expression and phosphorylation | Validate checkpoint kinase activation |
| CRISPR knock-in | Endogenous protein tagging or mutation | Study histone modifications like H4T80 |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate the DNA damage checkpoint. For example, screens in cells treated with DNA-damaging agents can reveal synthetic lethal interactions with checkpoint components. These screens are powerful for discovering novel regulators and therapeutic targets.
Phosphoproteomics and Proteomics
Mass spectrometry-based phosphoproteomics can map the signaling cascade downstream of ATM/ATR, identifying substrates of CHK1/CHK2 and other checkpoint kinases. Proteomic approaches can also quantify protein-protein interactions and complex assembly at DNA damage sites.
Live-Cell Imaging and Flow Cytometry
Fluorescent reporters for cell cycle phase (e.g., FUCCI) and DNA damage markers (e.g., γH2AX) allow real-time monitoring of checkpoint activation and recovery in single cells. Flow cytometry can quantify cell cycle arrest and apoptosis in response to genotoxic stress.
Transcriptomics and RNA-Seq
RNA-seq can measure changes in gene expression upon checkpoint activation, including p53 target genes and repair pathways. It can also reveal splicing changes mediated by SRSF2 and other RNA-binding proteins.
How CRISPR Can Be Used to Study GO:2000001 regulation of DNA damage checkpoint
Knockout
CRISPR knockout of checkpoint genes (e.g., ATM, CHEK1, TP53) is used to abrogate checkpoint function and study its role in cell cycle arrest, DNA repair, and sensitivity to DNA-damaging agents. Knockout cell lines are valuable for identifying synthetic lethal interactions and for validating drug targets.
Point Mutation
Point mutations in checkpoint genes, such as TP53 R175H or SRSF2 P95H, can be introduced via CRISPR to model disease-associated variants and dissect their impact on checkpoint regulation. These models are essential for understanding how specific mutations alter protein function and contribute to disease.
Knock-in
Knock-in of tagged versions of checkpoint proteins (e.g., GFP-ATM) or histone variants (e.g., H4T80A) allows real-time imaging and biochemical analysis of checkpoint dynamics. Knock-in models also enable the study of endogenous protein interactions and post-translational modifications.
Overexpression
Overexpression of checkpoint regulators (e.g., hMOB2, WIP1) can be achieved by CRISPR activation or lentiviral delivery to study gain-of-function effects on checkpoint activity and cell cycle progression. Overexpression models are useful for identifying dominant-negative or hyperactive phenotypes.
How EDITGENE Supports regulation of DNA damage checkpoint Research
Researchers studying regulation of DNA damage checkpoint-related genes often need to determine whether a candidate gene is causally involved in checkpoint control, how specific mutations affect protein function, and whether targeting the gene can sensitize cancer cells to therapy. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of DNA damage checkpoint research.
Frequently Asked Questions About regulation of DNA damage checkpoint
What is GO:2000001 regulation of DNA damage checkpoint?
GO:2000001 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of a DNA damage checkpoint, which arrests the cell cycle in response to DNA damage.
What genes are involved in regulation of DNA damage checkpoint?
Key genes include ATM, ATR, CHEK1, CHEK2, TP53, CDKN1A, CDC25A, CDC25C, WEE1, and SRSF2, among others.
How does the DNA damage checkpoint work?
Sensor kinases ATM/ATR detect DNA damage and activate CHK1/CHK2, which inhibit CDC25 phosphatases and stabilize p53, leading to cell cycle arrest and repair.
Why is regulation of DNA damage checkpoint important in cancer?
Loss of checkpoint function leads to genomic instability and cancer, while checkpoint activation can cause chemoresistance; targeting checkpoint kinases is a therapeutic strategy.
What diseases are associated with defects in DNA damage checkpoint?
Cancer, ataxia-telangiectasia, Li-Fraumeni syndrome, myelodysplastic syndromes, and immunodeficiency are linked to checkpoint defects.
How can CRISPR be used to study regulation of DNA damage checkpoint?
CRISPR knockout, point mutation knock-in, and overexpression models allow functional dissection of checkpoint genes and their roles in disease.
What methods are used to study the DNA damage checkpoint?
Common methods include CRISPR screens, phosphoproteomics, live-cell imaging, flow cytometry, RNA-seq, and immunoblotting.
What is checkpoint recovery?
Checkpoint recovery is the active process of turning off the checkpoint after DNA repair, allowing the cell cycle to resume; it involves phosphatases like WIP1 and histone modifications such as H4T80 phosphorylation.
How does SRSF2 regulate the DNA damage checkpoint?
SRSF2 safeguards efficient transcription of DNA damage and repair genes; its mutation impairs checkpoint activation and contributes to myelodysplasia.
What is the role of p53 in the DNA damage checkpoint?
p53 is a transcription factor stabilized by ATM/ATR signaling that induces p21, causing cell cycle arrest and allowing DNA repair or apoptosis.
Conclusion
GO:2000001 regulation of DNA damage checkpoint is a fundamental biological process that safeguards genome integrity by coordinating cell cycle arrest with DNA repair. Its dysregulation is implicated in cancer, immune disorders, and aging, making it a prime target for therapeutic intervention. Advances in CRISPR technology and functional genomics have accelerated the discovery of novel checkpoint regulators and their mechanisms. EDITGENE provides end-to-end CRISPR solutions, from knockout and knock-in models to library screening and bioinformatics, empowering researchers to dissect the regulation of DNA damage checkpoint with precision and speed.
References
- 1. Matthews HK et al.. 2022. Cell cycle control in cancer.. Nat Rev Mol Cell Biol 23(1):74-88 PMID: 34508254
- 2. Glaviano A et al.. 2025. Cell cycle dysregulation in cancer.. Pharmacol Rev 77(2):100030 PMID: 40148026
- 3. Hafner A et al.. 2019. The multiple mechanisms that regulate p53 activity and cell fate.. Nat Rev Mol Cell Biol 20(4):199-210 PMID: 30824861
- 4. Wagner RE et al.. 2024. SRSF2 safeguards efficient transcription of DNA damage and repair genes.. Cell Rep 43(11):114869 PMID: 39446588
- 5. Barnum KJ et al.. 2014. Cell cycle regulation by checkpoints.. Methods Mol Biol 1170:29-40 PMID: 24906307
- 6. Millan-Zambrano G et al.. 2018. Phosphorylation of Histone H4T80 Triggers DNA Damage Checkpoint Recovery.. Mol Cell 72(4):625-635.e4 PMID: 30454561
- 7. Gomez V et al.. 2015. Regulation of DNA damage responses and cell cycle progression by hMOB2.. Cell Signal 27(2):326-39 PMID: 25460043
- 8. Bednarski JJ et al.. 2019. At the intersection of DNA damage and immune responses.. Nat Rev Immunol 19(4):231-242 PMID: 30778174
